DARLINGTON HART: Open Payments
NPI 1154321164 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 38 payments from 10 companies in 2025. Trend: 2023 $951 · 2024 $1,168 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $185 |
| Amgen Inc. | 11 | $179 |
| Novo Nordisk Inc | 8 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $116 |
| Davol Inc. | 1 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Lilly USA, LLC | 1 | $25 |
| PFIZER INC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
Products named: Kerendia, KRYSTEXXA, Phasix Mesh, FARXIGA, Repatha, Wegovy, AIRSUPRA, BREZTRI.
Industry payments across NC — which companies pay providers there.
